» Articles » PMID: 16414555

Asking the Community About Cutpoints Used to Describe Mild, Moderate, and Severe Pain

Overview
Journal J Pain
Specialties Neurology
Psychiatry
Date 2006 Jan 18
PMID 16414555
Citations 49
Authors
Affiliations
Soon will be listed here.
Abstract

Unlabelled: Clinical practice guidelines recommend that numeric rating scales be used to document the severity of perceived pain, yet patients and clinicians often opt to use simpler classification systems such as mild, moderate, or severe. To assess how well the numeric scales correlate with the tri-level classification system for describing pain severity, we conducted a subanalysis of a larger population-based study of pain management preferences. Our primary objective was to identify the numeric boundaries used by 287 adults to describe pain as mild, moderate, or severe. We examined differences in the means of the upper and lower limits for mild, moderate, and severe pain according to demographic characteristics and type of pain. Ranges reported for each pain level were 1.3 to 3.6 (mild), 4.3 to 6.5 (moderate), and 7.5 to 9.8 (severe). The primary finding was that "healthy" community adults rated the pain severity cutpoints much as patients with clinical pain did, 1 to 4 for mild, 5 to 6 for moderate, and 7 to 10 for severe. These results suggest that numeric rating scales can be used in clinical practice with both patients and community-dwelling adults. Our findings also support encouraging the general public to use a 0 to 10 scale to rate their pain intensity.

Perspective: Methods used to describe numeric cutpoints for mild, moderate, and severe pain were applied to community adults. Having standard categories to describe pain severity might increase clinicians' confidence in using a numeric scale to make treatment decisions. Further studies of cutpoint methodology and its clinical importance are warranted.

Citing Articles

Educational level and gender are associated with emotional well-being in a cohort of Dutch dialysis patients.

Bakker W, Theunissen M, Ozturk E, Litjens E, Courtens A, van den Beuken-van Everdingen M BMC Nephrol. 2024; 25(1):179.

PMID: 38778249 PMC: 11112868. DOI: 10.1186/s12882-024-03617-8.


Scoring Abdominal Symptoms in People with Cystic Fibrosis.

Tabori H, Barucha A, Zagoya C, Duckstein F, Dunay G, Sadrieh P J Clin Med. 2024; 13(6).

PMID: 38541878 PMC: 10971656. DOI: 10.3390/jcm13061650.


Caregiver Perspectives on Pain Sensitivity and Pain Experience in Rett Syndrome.

Byiers B, Merbler A, Raiter A, Burkitt C, Symons F Can J Pain. 2023; 7(1):2229400.

PMID: 37533505 PMC: 10392763. DOI: 10.1080/24740527.2023.2229400.


Health-related quality of life in parents of adolescents one year into the COVID-19 pandemic: a two-year longitudinal study.

Rohde G, Helseth S, Skarstein S, Smastuen M, Mikkelsen H, Haraldstad K Health Qual Life Outcomes. 2022; 20(1):158.

PMID: 36457113 PMC: 9713202. DOI: 10.1186/s12955-022-02069-8.


Perspectives on adapting a mobile application for pain self-management in neurofibromatosis type 1: results of online focus group discussions with individuals living with neurofibromatosis type 1 and pain management experts.

Grau L, Larkin K, Lalloo C, Stinson J, Zempsky W, Ball S BMJ Open. 2022; 12(7):e056692.

PMID: 35840301 PMC: 9295671. DOI: 10.1136/bmjopen-2021-056692.